UNSPSC 51162406: Acetaminophen/dextromethorphan/pseudoephedrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class RE515. This VA Drug Class (RE515) classifies this compound as belonging to the group DECONGESTANT/ANTITUSSIVE/ANALGESIC.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51162406 Acetaminophen/dextromethorphan/pseudoephedrine is a Commodity code that, based on recent state and local solicitations, encompasses over-the-counter and generic pharmaceutical products distributed to public health agencies, community health facilities, and state and local government entities. The recent opportunities reveal that state and local governments procure not only the specific combination product named in the code but also broader OTC and generic pharmaceutical inventories, including naloxone and drug deactivation systems for emergency response and community health initiatives. Issuing bodies include county health departments (Seminole County, Florida) and multistate cooperative purchasing alliances administering purchases across multiple states and localities. The code sees activity from county public health agencies pursuing direct procurement for specific community health programs, as well as from state-level cooperative purchasing vehicles establishing master agreements for broader distribution across multiple participating jurisdictions.

Recent activity spans Florida and Minnesota, with the most current opportunity being the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) Request for Proposal for generic multi-source pharmaceuticals and OTC products, due March 26, 2026, which establishes multiple contracts for distribution through authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co.) to participating state and local government facilities across Minnesota and Oregon, with award effective July 1, 2026. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building, with a bid deadline of July 26, 2023. The MMCAP procurement weights price competitiveness at 75 percent, requires compliance with current Good Manufacturing Practices and the Drug Supply Chain Security Act, and imposes a 3 percent administrative fee; vendors must maintain relationships with at least two of three authorized wholesalers and provide comprehensive pricing in multiple formats (flat price, net price, or WAC-minus structures).